secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001493152-24-009898
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed subsidiary Lucid Diagnostics raises $12.5M via Series B Preferred Stock offering and exchange
--------------------------------------------------------------------------------

- Lucid Diagnostics sold 12,495 shares of Series B Convertible Preferred at $1,000/share, raising $12.495M.
- Investors exchanged 13,625 Series A and 10,670 Series A-1 shares for 31,790 Series B shares.
- Closing on March 13, 2024; Lucid filed certificate of designation for Series B and amendment for Series A-1.
- Registration rights agreement filed for resale of common stock issuable upon conversion of Series B Preferred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224009898/0001493152-24-009898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224009898/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer